Ondine Biomedical Inc. (LON:OBI – Get Free Report)’s share price rose 1.5% during trading on Friday . The company traded as high as GBX 8.25 ($0.10) and last traded at GBX 8.25 ($0.10). Approximately 29,881 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 331,950 shares. The stock had previously closed at GBX 8.13 ($0.10).
Ondine Biomedical Trading Up 1.5 %
The stock has a fifty day simple moving average of GBX 7.23 and a 200 day simple moving average of GBX 7.45. The company has a debt-to-equity ratio of 1,847.37, a quick ratio of 8.26 and a current ratio of 0.80. The firm has a market cap of £22.88 million, a P/E ratio of -275.00 and a beta of 0.10.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Featured Articles
- Five stocks we like better than Ondine Biomedical
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Tesla Investors Continue to Profit From the Trump Trade
- Using the MarketBeat Dividend Yield Calculator
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Consumer Discretionary Stocks Explained
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
